Lifesci Acquisition II

General Information

We intend to focus on businesses that have their primary operations located in North America in the healthcare industry. it is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting companies domiciled in North America or Europe that are developing assets in the biopharma, medical technology, digital health, and healthcare services sectors, which aligns with our management team’s experience in healthcare investing and drug development. 

Our management team is led by Andrew McDonald, Co-Founder of LifeSci Advisors and LifeSci Capital; Michael Rice, Co-Founder of LifeSci Advisors and LifeSci Capital, and David Dobkin, Managing Director of LifeSci Capital.

Our sponsor is an affiliate of LifeSci Capital LLC, a research-driven investment bank with deep domain expertise in the life sciences; LifeSci Advisors LLC, an investor relations and public relations company in the life sciences industry with comprehensive solutions to communications and investor outreach, and LifeSci Venture Management LLC, a corporate venture capital firm that seeks to invest in biotech and health sectors, collectively “LifeSci”.

LifeSci’s service model as a boutique investment bank is unique in that it exclusively serves corporate clients that are emerging life science companies that discover, develop, and commercialize innovative products.

Employees: 0
Founded: 2019
Contact Information
Address 250 W 55th St #3401, New York, NY 10019
Phone Number (646) 889-1200
Web Address
View Prospectus: Lifesci Acquisition II
Financial Information
Market Cap $93.75mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol LSAQ
Exchange NASDAQ
Shares (millions): 7.5
Price range $10.00 - $10.00
Est. $ Volume $75.0 mil
Manager / Joint Managers LifeSci Capital/ Ladenburg Thalmann
CO-Managers -
Expected To Trade: 11/20/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change